BioStrand

Foundation date

06/02/2019

Sector

#Biotechnology / R&D Services

Subsector

BioStrand is the first company since the 1980s to come up with a completely new, out-of-the-box solution for genetic data analysis. Where next generation sequencing revolutionised sequence data generation in the last decade, BioStrand now revolutionises sequence data analysis.

BioStrand offers a revolutionary methodology for identifying similarities and variations in genetic data and detecting structural anchor points that will drive innovation.

The BioStrand methodology enables unprecedented accuracy and speed of operation in detecting similarities and variations in DNA, RNA and proteins. By detecting HYFTSTM, structural 3D information is automatically integrated into the analyses,  revolutionising  pattern and profile detection that are critical in understanding diseases and biological processes.

Upcoming events

Latest news

  • Company growth prompts Connected-Pathology relocation to larger laboratory facilities to accommodate increase in study capacity

    1 day ago

  • Japan welcomes companies, startups and knowledge institutions from Flanders

    Friday December 2nd 2022

  • FIT stimulates market diversification with renewed subsidy

    Thursday December 1st 2022